AtriCure (ATRC) CEO reports family stock gifts in Form 4

Rhea-AI Filing Summary

AtriCure, Inc. President, CEO, and Director Michael H. Carrel reported bona fide gifts totaling 6,000 shares of AtriCure common stock on March 6, 2026, consisting of separate transfers of 5,000 shares and 1,000 shares. No consideration was received for these gifts to his children and sibling, and his directly owned stake was reported as 778,498 shares following the gifts. He also reported indirect holdings held by his children, parents, and sibling, and disclaimed beneficial ownership of those indirect holdings except for his pecuniary interest.

Insider Trade Summary

6,000 shares gifted

Mixed 5 txns

Insider CARREL MICHAEL H

Role President, CEO, & Director

Type	Security	Shares	Price	Value
Gift	Common Stock	5,000	$0.00	--
Gift	Common Stock	1,000	$0.00	--
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 779,498 shares (Direct); Common Stock — 14,310 shares (Indirect, Held by reporting person's children)

Footnotes (1)

1. No consideration was received in connection with this gift to the reporting person's children. No consideration was received in conjunction with this gift to the reporting person's sibling. The reporting person disclaims beneficial ownership of these securities, except as to his pecuniary interest therein.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

CARREL MICHAEL H

(Last) (First) (Middle)

7555 INNOVATION WAY

(Street)

MASON OH 45040-9695

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
AtriCure, Inc. [ ATRC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President, CEO, & Director

3. Date of Earliest Transaction (Month/Day/Year)
03/06/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/06/2026		G	V	5,000	D	$0(1)	779,498	D
Common Stock	03/06/2026		G	V	1,000	D	$0(2)	778,498	D
Common Stock								14,310	I	Held by reporting person's children(3)
Common Stock								2,250	I	Held by reporting person's parents(3)
Common Stock								1,000	I	Held by reporting person's sibling(3)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. No consideration was received in connection with this gift to the reporting person's children.

2. No consideration was received in conjunction with this gift to the reporting person's sibling.

3. The reporting person disclaims beneficial ownership of these securities, except as to his pecuniary interest therein.

Remarks:

	/s/ Michael H. Carrel	03/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did AtriCure (ATRC) CEO Michael Carrel report in this Form 4?

Michael H. Carrel reported bona fide gifts of AtriCure common stock. He transferred 5,000 shares and 1,000 shares on March 6, 2026, as gifts to family members, with no consideration received, and updated his direct and indirect ownership positions accordingly.

How many AtriCure (ATRC) shares did the CEO gift and to whom?

The CEO gifted a total of 6,000 AtriCure common shares. One 5,000-share gift was made to his children and a 1,000-share gift to his sibling, both characterized as bona fide gifts with no consideration received in connection with these transfers.

How many AtriCure (ATRC) shares does the CEO own directly after the gifts?

After the reported gifts, Michael H. Carrel’s direct ownership was 778,498 AtriCure common shares. This figure reflects his remaining directly held stake following the two bona fide gift transactions reported for March 6, 2026, and excludes shares held indirectly by family members.

What indirect AtriCure (ATRC) holdings associated with the CEO are disclosed?

Indirect holdings disclosed include shares held by the reporting person’s children, parents, and sibling. These positions are reported as indirect ownership, and the CEO disclaims beneficial ownership of those securities except to the extent of his pecuniary interest in them.

Were the AtriCure (ATRC) share transfers sales or gifts?

The reported transfers were bona fide gifts, not sales. The Form 4 uses transaction code G, and footnotes state that no consideration was received for the gifts to the reporting person’s children and sibling, distinguishing them from open-market or compensatory transactions.

Does the AtriCure (ATRC) CEO claim full beneficial ownership of family-held shares?

No. A footnote states that the reporting person disclaims beneficial ownership of the family-held securities, except as to his pecuniary interest. This means he does not assert full beneficial ownership over those indirect holdings attributed to his children, parents, and sibling.